These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1699766)

  • 41. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
    Carter HB; Morrell CH; Pearson JD; Brant LJ; Plato CC; Metter EJ; Chan DW; Fozard JL; Walsh PC
    Cancer Res; 1992 Jun; 52(12):3323-8. PubMed ID: 1375867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland.
    Oyen RH; Van de Voorde WM; Van Poppel HP; Brys PP; Ameye FE; Franssens YM; Baert AL; Baert LV
    Radiology; 1993 Dec; 189(3):707-11. PubMed ID: 7694310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between prostate specific antigen, prostate volume and age in the benign prostate.
    Collins GN; Lee RJ; McKelvie GB; Rogers AC; Hehir M
    Br J Urol; 1993 Apr; 71(4):445-50. PubMed ID: 7684650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.
    Carter HB; Pearson JD; Metter EJ; Brant LJ; Chan DW; Andres R; Fozard JL; Walsh PC
    JAMA; 1992 Apr 22-29; 267(16):2215-20. PubMed ID: 1372942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biopsy-based diagnosis of prostate cancer in 1290 patients referred for prostate examination: results according to the PSA level, digital rectal examination and ultrasonography.
    Szabó J; Végh A; Gasman D; Hoznek A; Chopin DK; Abbou CC
    Acta Chir Hung; 1998; 37(1-2):95-100. PubMed ID: 10196617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Color Doppler and ultrasound-guided prostate biopsy in the diagnosis of prostatic neoplasm].
    Maruzzi D; Marin A; Lenardon O; Ostardo E; Sangiorgio A; Merlo A; Garbeglio A
    Arch Ital Urol Androl; 2000 Dec; 72(4):174-81. PubMed ID: 11221032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate-specific antigen levels and density in the internal and external glands of the prostate in benign prostatic hyperplasia patients with normal or gray-zone PSA levels.
    Zuo W; Hiraoka Y
    Urol Int; 2003; 71(2):154-9. PubMed ID: 12890952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prostate-specific antigen in patients with benign prostatic hyperplasia].
    Goncalves F; Kausitz J; Bárdos A; Miklosi M
    Rozhl Chir; 1994 Sep; 73(6):291-3. PubMed ID: 7536350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies.
    De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Milillo A; Papotti M; Porpiglia F
    BJU Int; 2014 Dec; 114(6b):E56-E61. PubMed ID: 24472071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.
    Hasui Y; Marutsuka K; Asada Y; Ide H; Nishi S; Osada Y
    Prostate; 1994 Aug; 25(2):91-6. PubMed ID: 7518599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of prostate-specific antigen in untreated prostatic carcinoma.
    Oosterom R; Bogdanowicz J; Schröder FH
    Eur Urol; 1989; 16(4):253-7. PubMed ID: 2475344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of patients with diseases of the prostate using prostate-specific antigen density.
    Wolff JM; Boeckmann W; Effert PJ; Handt S; Jakse G
    Br J Urol; 1995 Jul; 76(1):41-6. PubMed ID: 7544203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate cancer and the role of color Doppler US.
    Kelly IM; Lees WR; Rickards D
    Radiology; 1993 Oct; 189(1):153-6. PubMed ID: 7690489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinicopathologic and biological correlations (PSA-PAP) in pathology of the prostate. Apropos of 150 cases].
    Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
    J Urol (Paris); 1990; 96(4):199-201. PubMed ID: 1698882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Correlation of Prostate Volume and Prostate-specific Antigen Levels With Positive Bacterial Prostate Tissue Cultures.
    Heidler S; Drerup M; Lusuardi L; Bannert U; Bretterbauer K; Bures J; Dietersdorfer F; Dlouhy-Schütz E; Hessler C; Karpf R; Mittellehner LA; Mitlöhner B; Schwarz S; Thomay G; Lösch G; Freibauer C; Albrecht W
    Urology; 2018 May; 115():151-156. PubMed ID: 29526510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of prostatic measuring by transrectal ultrasound in surgical management of patients with clinically benign prostatic hyperplasia.
    Milonas D; Trumbeckas D; Juska P
    Medicina (Kaunas); 2003; 39(9):860-6. PubMed ID: 14515048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of prostate specific antigen and gamma-seminoprotein ratio: a new means of distinguishing benign prostatic hyperplasia and prostate cancer.
    Demura T; Watarai Y; Togashi M; Hirano T; Ohashi N; Koyanagi T
    J Urol; 1993 Nov; 150(5 Pt 2):1740-5. PubMed ID: 7692111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.